Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
KTTA - Pasithea Therapeutics Corp.
Market Cap 15.47M P/E - EPS this Y - Ern Qtrly Grth -
Income -15.51M Forward P/E -0.83 EPS next Y - 50D Avg Chg 24.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -4.00%
Dividend N/A Price/Book 0.40 EPS next 5Y - 52W High Chg -62.00%
Recommedations 2.00 Quick Ratio 6.22 Shares Outstanding 1.04M 52W Low Chg 91.00%
Insider Own 140.58% ROA -28.02% Shares Float 748.76K Beta 0.88
Inst Own 23.87% ROE -47.07% Shares Shorted/Prior 8.71K/9.18K Price 0.59
Gross Margin - Profit Margin - Avg. Volume 233,632 Target Price -
Oper. Margin - Earnings Date May 12 Volume 39,437 Change 0.39%
Healthcare | Biotechnology | United States
About Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for Central Nervous System disorders, RASopathies, and other diseases. It operates through two segments, Therapeutics and Clinics. The company provides business support services to anti-depression clinics, entities, and registered healthcare providers. Its lead product candidate PAS-004, a next-generation mitogen-activated protein kinase, or MEK inhibitor designed to be macrocyclic for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 and Noonan syndrome, as well as lamin A/C cardiomyopathy and oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; PAS-002, for the treatment multiple sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Pasithea Therapeutics Corp. News
02/13/24 Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
01/08/24 Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position
01/02/24 Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients
12/28/23 Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023
05:19 PM Pasithea Therapeutics Announces Results from 2023 Annual Meeting
12/11/23 Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models
11/29/23 Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders
11/29/23 Pasithea Therapeutics Announces Outcome of Pre-IND Meeting with FDA for PAS-004 Clinical Development
11/09/23 Pasithea Therapeutics Selects PAS-003 Lead Development Candidate, a Humanized Monoclonal Antibody that Targets α5β1 Integrin for the Treatment of both Sporadic and Familial ALS
09/14/23 Pasithea Therapeutics Corp. Announces Final Results of Tender Offer
09/07/23 Pasithea Therapeutics to Participate in H.C. Wainwright 25th Annual Global Investment Conference
08/01/23 Pasithea Therapeutics publishes study in Proceedings of the National Academy of Sciences (PNAS) that shows an increase in α5 integrin expression in ALS human and mouse brain tissue, and further demonstrates targeting α5 integrin results in improved survival and motor function
07/20/23 Pasithea Therapeutics Announces Intention to Commence a $4.0 Million Tender Offer for its Common Stock at Price of $0.70 per Share in Cash
07/20/23 Pasithea Therapeutics Special Committee Rejects Unsolicited Bid from Lucy Scientific Discovery, Inc.
07/13/23 Lucy Scientific Scores Richard Nanula as CEO After Senior Roles at Disney, Amgen, Starwood
06/30/23 Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors
06/29/23 Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics Corp.
06/29/23 Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004
06/06/23 Pasithea Therapeutics Confirms Receipt of Unsolicited Proposal from Lucy Scientific Discovery Inc.
06/05/23 Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp.
KTTA Chatroom

User Image ClassifiedTrades Posted - 2 weeks ago

$KTTA kind of looking interesting too, should be on watchlist coming up sessions , $REVB $CADL CPOP

User Image SchichtTheBritches Posted - 2 weeks ago

$KTTA this is dead af

User Image DorisRooker793 Posted - 03/25/24

$KTTA What's the potential for TREIF to disrupt the healthcare industry with AI?

User Image UtahSUV Posted - 03/22/24

$KTTA

User Image cryptopunk223 Posted - 4 weeks ago

$KTTA did we have a revert split here ? #carious

User Image Jajhrbdisn Posted - 1 month ago

$KTTA more dilution coming on this or no?

User Image isellnoloss Posted - 1 month ago

$BNZI $AGRI $KTTA $PHAT $AIRE

User Image isellnoloss Posted - 1 month ago

$KTTA $AGRI

User Image SchichtTheBritches Posted - 1 month ago

$KTTA market has been open over an hour and volume is literally ZERO

User Image tradingtwenty Posted - 1 month ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $HSDT 4.04M 🔥 $JAGX 4.49M $AIMD 4.91M $KTTA 8.47M $BNTC 14.57M Link: https://tradingtwenty.com/dashboard/trending/past

User Image skaryskillz Posted - 1 month ago

$KTTA Insiders buying stock options at $8.34 BULLISH AF

User Image skaryskillz Posted - 1 month ago

$KTTA they bought stock options i guess?

User Image skaryskillz Posted - 1 month ago

$KTTA here’s just one of them

User Image skaryskillz Posted - 1 month ago

$KTTA

User Image skaryskillz Posted - 1 month ago

$KTTA they just filed about 8 SEC filings - all insiders bought shares today at $8.34 price

User Image koalaballa Posted - 1 month ago

$KTTA 👏

User Image isellnoloss Posted - 02/29/24

$KTTA this stock will see 20$

User Image skaryskillz Posted - 02/29/24

$KTTA shout out to those of us holding long. this stock is worth $20+

User Image SchichtTheBritches Posted - 02/22/24

$KTTA volume 0 🤣

User Image Sutliff Posted - 02/20/24

$KTTA my Think or Swim isn’t showing any buys today! But it looks like 52 shares traded but didn’t get picked up on the chart. Damn!! Shorts aren’t shorting because they have no buyers to cover! Hahaha If this had volume it would skyrocket though

User Image skaryskillz Posted - 2 months ago

$KTTA booooooring

User Image skaryskillz Posted - 2 months ago

$KTTA lovely! just need volume some day. float is still as always, super low since the reverse split. ive been long here.

User Image HaltTradeAlert Posted - 2 months ago

$KTTA Halt Time: 14:35:46 Issue Symbol: KTTA Reason Code: LUDP Stock Price: $7.81 Market Cap: 8.132M Volume: 11,694 Relative Volume: 0.12 Shares Float: 754k Get this alert real time and sent to your phone just like a text by going to our website and joining our community for FREE! We just launched this service! Help us spread the word ! www.HaltTradeAlert.com

User Image skaryskillz Posted - 2 months ago

$KTTA oh yessss

User Image isellnoloss Posted - 2 months ago

$KTTA told ya keep owning this one....

User Image pointnopoint Posted - 2 months ago

$KTTA Two days ago, this is the latest news I've seen: Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004 Is there something else coming that's causing this spike?

User Image Sutliff Posted - 2 months ago

$KTTA I love this low volume rise in price. Nobody is selling but gradual buyers pushing it higher…keep it going 💰

User Image isellnoloss Posted - 2 months ago

$KTTA this company is accomplishing their benchmarks.

User Image isellnoloss Posted - 2 months ago

$KTTA like I said this morning pre-news I'm still here

User Image skaryskillz Posted - 2 months ago

$KTTA news - pump it $MLGO $DHAI $BMR $MRK

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
STEINMAN LAWRENCE Director Director Jun 02 Buy 0.431 30,000 12,930 1,327,174 06/06/23
Shahinian Eric Other Other Sep 28 Buy 1.17 64,357 75,298 1,788,415 09/30/22
Shahinian Eric Other Other Sep 01 Buy 1.13 88,901 100,458 1,724,058 09/06/22
Shahinian Eric Other Other Aug 29 Buy 1.16 22,828 26,480 1,635,157 08/31/22
Shahinian Eric - - Aug 17 Buy 1.2087 155,773 188,283 1,611,329 08/18/22